TERRENCE F. BLASCHKE, M.D. - Corporate Board Profile

DURECT CORP

Filing Date	Source Excerpt
2007-04-30	Terrence F. Blaschke, M.D. has served as a director since December 2006. Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology (Active Emeritus) at the Stanford University School of Medicine.
2008-04-29	Terrence F. Blaschke, M.D. has served as a director since December 2006. Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology (Active Emeritus) at the Stanford University School of Medicine.
2009-04-29	Terrence F. Blaschke, M.D. has served as a director since December 2006. Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology (Active Emeritus) at the Stanford University School of Medicine.
2010-04-29	Terrence F. Blaschke, M.D. has served as a director since December 2006. ... (3) Member of the Nominating & Corporate Governance Committee ... Director Compensation for Fiscal 2009: Terrence F. Blaschke, M.D. Fees Earned or Paid in Cash $40,000, Option Awards $32,324, Total $72,324.
2011-04-28	Terrence F. Blaschke, M.D. has served as a director since December 2006. ... The Nominating & Corporate Governance Committee was composed of Simon X. Benito, Terrence F. Blaschke and Michael D. Casey. ... Director Compensation for Fiscal 2010: Terrence F. Blaschke, M.D. $92,308.
2012-04-26	Terrence F. Blaschke, M.D. has served as a director since December 2006. ... The Nominating & Corporate Governance Committee was composed of Simon X. Benito, Terrence F. Blaschke and Michael D. Casey. ... Director Compensation for Fiscal 2011: Terrence F. Blaschke total $98,063.
2013-04-29	Terrence F. Blaschke, M.D. has served as a director since December 2006. Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology (Emeritus) at the Stanford University School of Medicine. ... Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience as relates to drug development are among the qualifications he brings to the Board and his service as a Director of the Company.
2014-04-23	Terrence F. Blaschke, M.D. has served as a director since December 2006. Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology (Emeritus) at the Stanford University School of Medicine. He is currently a senior program officer, Global Health Discovery and Translational Science at the Bill and Melinda Gates Foundation. Dr. Blaschke held the position of Vice President of Methodology and Science at Pharsight Corporation from 2000 to 2002. Dr. Blaschke has served as an independent consultant working with a number of leading pharmaceutical and biotechnology companies. Dr. Blaschke was formerly a board member of Therapeutic Discovery Corporation and Crescendo Pharmaceuticals, two publicly-traded companies. He has also worked as a special government employee for the U.S. Food and Drug Administration (FDA) and has served as the chairman of the FDA’s Generic Drugs Advisory Committee. Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience as relates to drug development are among the qualifications he brings to the Board and his service as a Director of the Company.
2015-04-22	Terrence F. Blaschke, M.D. has served as a director since December 2006. ... Dr. Blaschke's medical and scientific expertise and pharmaceutical industry experience as relates to drug development are among the qualifications he brings to the Board and his service as a Director of the Company.
2016-04-28	Terrence F. Blaschke, M.D. has served as a director since December 2006. Dr. Blaschke has served on the faculty of Stanford University since 1974 and is Professor of Medicine and Molecular Pharmacology (Emeritus) at the Stanford University School of Medicine.
2017-04-27	Terrence F. Blaschke, M.D. has served as a director since December 2006. ... The Nominating and Corporate Governance Committee was composed of Simon X. Benito, Terrence F. Blaschke and Armand P. Neukermans.
2018-04-27	Terrence F. Blaschke, M.D. has served as a director since December 2006. ... Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience as relates to drug development are among the qualifications he brings to the Board and his service as a Director of the Company.
2019-04-26	Terrence F. Blaschke, M.D. (3) 76 Director (3) Member of the Nominating and Corporate Governance Committee Director Compensation for Fiscal 2018 Terrence F. Blaschke, M.D. Fees Earned or Paid in Cash ($) 57,595 Option Awards ($) 90,244 Total ($) 147,839
2020-04-27	Terrence F. Blaschke, M.D. (3) 77 Director ... (3) Member of the Nominating and Corporate Governance Committee ... Director Compensation for Fiscal 2019 Terrence F. Blaschke, M.D. 46,500 Fees Earned or Paid in Cash ($) 29,935 Option Awards ($) 24,600 All Other Compensation ($) 101,035 Total ($)
2021-04-23	Terrence F. Blaschke, M.D. has served as a director since December 2006. ... Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience relating to drug development are among the qualifications he brings to the Board and his service as a Director of the Company.
2022-04-25	Terrence F. Blaschke, M.D. has served on our Board of Directors since December 2006. ... Dr. Blaschke was appointed as Chairman of the Research and Development Committee in June 2021. ... At the end of the last fiscal year, the Nominating and Corporate Governance Committee was composed of Mohammad Azab, Simon X. Benito, Terrence F. Blaschke and Judith J. Robertson. ... At the end of the last fiscal year, the Research and Development Committee was composed of Mohammad Azab, Terrence F. Blaschke and Gail M. Farfel.
2023-04-27	Terrence F. Blaschke, M.D.has served on our Board of Directors since December 2006. ... At the end of the last fiscal year, the Research and Development Committee was composed of Mohammad Azab, Terrence F. Blaschke and Gail M. Farfel. Dr. Blaschke was appointed as Chair of the Committee in June 2021. ... Director Compensation for Fiscal 2022: Terrence F. Blaschke, M.D. Fees Earned or Paid in Cash ($) 60,000, Option Awards ($) 23,150, Total ($) 83,150.
2024-08-12	Terrence F. Blaschke, M.D. has served on our Board of Directors since December 2006. Dr. Blaschke is Professor of Medicine and Molecular Pharmacology (Emeritus) at Stanford University School of Medicine. Dr. Blaschke’s medical and scientific expertise and pharmaceutical industry experience relating to drug development are among the qualifications he brings to our Board of Directors. Director Compensation for Fiscal 2023 shows cash fees of $60,000 and option awards valued at $23,115, totaling $83,115.